{"id":"S89006947","label":"Recombinant erythropoietin","description":"","source_url":"https://id.loc.gov/authorities/subjects/sh89006947","normalized_label":"recombinant erythropoietin","broader":["http://id.loc.gov/authorities/subjects/sh85044756","http://id.loc.gov/authorities/subjects/sh91005675"],"aliases":["Epoetin","Epogen (Trademark)","Erythropoietin--Genetic engineering","Genetically engineered erythropoietin"],"source_identifier":"http://id.loc.gov/authorities/subjects/sh89006947","provider":"lcsh","revision":"68cc64efbd310406","taxonomy_revision":"f050b5d4780b1289","title":"Recombinant erythropoietin","url":"/topics/S89006947","kind":"topic-directory","aeo_cohort":"topic-directory","catalogue_revision":"f050b5d4780b1289","numeric_address":"9242732238670546438","address_version":"morton4x16-v1","coordinates":[0,21,14477,35840],"answer_status":"Directory metadata; local answer requires separate source review","truth_status":"Subject descriptor, not a factual answer or a demonstrated knowledge gap","reviewed_answer":null}